Rising costs of drug development, coupled with increasing regulatory pressures, have driven life sciences organizations to reimagine the way clinical trials are conducted – the focus is increasingly shifting toward failing fast and failing cheap. However, challenges such as siloed data management, delayed timelines due to patient recruitment concerns, and a complex environment of varied technology solutions compound a pharma organization’s woes. Digital technologies and products are being deployed across the clinical trial landscape to resolve these challenges and bring in efficiencies and automation to reduce manual errors.
Recently, product vendors have started integrating siloed point solutions into an integrated, modular, and interoperable end-to-end clinical development platform – a single platform that addresses a pharma organization’s needs, right from study start-up to study close-out. A single-platform estate enables efficient data management, reduces the total cost of ownership, and improves the visibility of operations. However, pharma executives are yet to be convinced about this unified platform approach.
In this research, we present a detailed assessment of 21 IT vendors featured on Everest Group’s Clinical Development Platforms Products PEAK Matrix® 2020. Each provider assessment includes Everest Group’s remarks on the product vendor, ratings across metrics for market impact and vision and strategy, and a detailed profile with case studies and recent developments. The assessment is based on Everest Group’s annual RFI process for the calendar year 2020, interactions with leading clinical development product vendors, client reference checks, and an ongoing analysis of the clinical development products market.
This research studies the following clinical development platform vendors: Accenture, ArisGlobal, BioClinica, Bio-Optronics, Castor, CliniOps, Cognizant, Covance, Datatrak, eClinicalHealth, Ennov, IBM, IQVIA, Medidata, Mednet, Navitas Life Sciences, Oracle, Parexel, PRA Health Sciences, TCS, and Veeva Systems.
This report features 21 clinical development product vendor profiles, and includes: